MedPath

Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new smoothie-style paediatric sip feed in children in need of oral nutritional support.

Phase 2
Conditions
ondervoeding en andere redenen waarom een kind niet (genoeg) groeit.
Failure to thrive
Malnutrition
10003018
Registration Number
NL-OMON34977
Lead Sponsor
Danone Research - Centre for Specialised Nutrition
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
19
Inclusion Criteria

- Male and female subjects, aged 3-12 years (including 3 and 12 years) in need of oral nutritional support (subject can be current or new paediatric sip feed user).
- Subject requires a paediatric sip feed for at least 6 weeks.
- Both hospitalized subjects and out-patients.
- Stable health status and expected to remain stable throughout the study (in the opinion of the Health Care Professional).
- Written informed consent from parents/guardian and subject (if applicable according to local law).

Exclusion Criteria

- Cow*s milk allergy, known inflammatory bowel disease, bowel resection.
- Subjects requiring a fibre-free diet.
- Known allergy for fruit (apple, pear, strawberry, raspberry, banana, apricot, lemon) and/or carrot.
- Subjects requiring an adult rather than a paediatric sip feed.
- Major renal dysfunction (if requiring, but not yet receiving, dialysis).
- Major hepatic dysfunction (e.g. hepatitis, congenital abnormalities affecting the liver).
- Major gastrointestinal intolerance (e.g. vomiting, diarrhoea).
- Inherited metabolic disorders, including galactosaemia.
- Use of parenteral feeding and/or enteral tube-feeding.
- Investigator's uncertainty about the willingness or ability of the child/carer to comply with the protocol requirements.
- Participation in any other study involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath